"Lymphopenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Reduction in the number of lymphocytes.
Descriptor ID |
D008231
|
MeSH Number(s) |
C15.378.553.546.605 C20.673.627
|
Concept/Terms |
Lymphopenia- Lymphopenia
- Lymphopenias
- Lymphocytopenia
- Lymphocytopenias
|
Below are MeSH descriptors whose meaning is more general than "Lymphopenia".
Below are MeSH descriptors whose meaning is more specific than "Lymphopenia".
This graph shows the total number of publications written about "Lymphopenia" by people in this website by year, and whether "Lymphopenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2016 | 2 | 0 | 2 |
2017 | 3 | 0 | 3 |
2019 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphopenia" by people in Profiles.
-
Tran P, Jamee M, Pournasiri Z, Chavoshzadeh Z, Sullivan KE. SGPL1 Deficiency: Nephrotic Syndrome with Lymphopenia. J Clin Immunol. 2023 01; 43(1):72-75.
-
Deshpande DR, Demirdag YY, Marsh RA, Sullivan KE, Orange JS. Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study. J Clin Immunol. 2021 01; 41(1):29-37.
-
Younan P, Santos RI, Ramanathan P, Iampietro M, Nishida A, Dutta M, Ammosova T, Meyer M, Katze MG, Popov VL, Nekhai S, Bukreyev A. Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection. PLoS Pathog. 2019 10; 15(10):e1008068.
-
Chuang E, Augustine M, Jung M, Schwartz RH, Singh NJ. Density dependent re-tuning of autoreactive T cells alleviates their pathogenicity in a lymphopenic environment. Immunol Lett. 2017 12; 192:61-71.
-
Sullivan KE, Crowley TB, Maurer K, Goldmuntz E, Gaynor JW, Zackai E, McDonald-McGinn D. T-cell lymphopenia in 22q11.2 deletion syndrome: Relationship to cardiac disease. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):690-691.
-
Jyonouchi S, Jongco AM, Puck J, Sullivan KE. Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia. J Clin Immunol. 2017 May; 37(4):363-374.
-
Sullivan KE, Burrows E, McDonald McGinn DM. Healthcare utilization in chromosome 22q11.2 deletion patients with cardiac disease and low T cell counts. Am J Med Genet A. 2016 06; 170(6):1630-4.
-
Morsheimer MM, Rychik J, Forbes L, Dodds K, Goldberg DJ, Sullivan K, Heimall JR. Risk Factors and Clinical Significance of Lymphopenia in Survivors of the Fontan Procedure for Single-Ventricle Congenital Cardiac Disease. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):491-6.
-
Maggadottir SM, Sullivan KE. The intersection of immune deficiency and autoimmunity. Curr Opin Rheumatol. 2014 Sep; 26(5):570-8.
-
Killebrew JR, Perdue N, Kwan A, Thornton AM, Shevach EM, Campbell DJ. A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease. J Immunol. 2011 Jul 15; 187(2):861-9.